• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Firocoxib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758484

Firocoxib is a selective non-steroidal inhibitor of cycooxygenase-2 (COX-2) (IC50 of 0.13uM), with anti-inflammatory for use in dogs and horses. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Firocoxib, Inhibitor
Full Product Name
Firocoxib
Product Synonym Names
ML 1785713
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
336.40
Solubility
DMSO: 47mg/ml (139.71mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C17H20O5S
SMILES
CC1(C)OC(=O)C(OCC2CC2)=C1C1=CC=C(C=C1)S(C)(=O)=O
CAS Number
189954-96-9
Target & IC50
COX-2: ic50 0.13uM
COX-1: ic50 7.5uM

Structure of Firocoxib, inhibitor

Firocoxib Inhibitor – Cat# MBS5758484

Product References and Citations for Firocoxib, inhibitor

Stock ML, et al. Pharmacokinetics of firocoxib in preweaned calves after oral and intravenous administration. J Vet Pharmacol Ther. 2014 Oct;37(5):457-63.
Stock ML, et al. Pharmacokinetics of firocoxib in preweaned calves after oral and intravenous administration. J Vet Pharmacol Ther. 2014 Oct;37(5):457-63.
Albanese F, et al. Clinical outcome and cyclo-oxygenase-2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib. Vet Dermatol. 2013 Dec;24(6):606-12, e147.
Albanese F, et al. Clinical outcome and cyclo-oxygenase-2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib. Vet Dermatol. 2013 Dec;24(6):606-12, e147.

Other Notes

Small volumes of Firocoxib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Firocoxib purchase

MBS5758484 is an inhibitor targeting Firocoxib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000